June 22 (Reuters) – Erica Schwartz, President Donald Trump’s nominee to lead the U.S. Centers for Disease Control and Prevention, said she will resign from UnitedHealth and board roles, sell healthcare-related holdings and recuse herself from matters involving former employers and clients if confirmed, in a financial disclosure to the HHS Ethics counsel.
Here are some details from the letter dated June 16:
• Schwartz said her employment with insurer UnitedHealth Group will end upon confirmation, and she will receive a cash payment equal to one year’s salary and a bonus before assuming the CDC role, or forfeit the money.
• She said UnitedHealth also agreed to cash out certain unvested restricted stock units and unvested stock options that would otherwise have vested between August 2026 and August 2027, while any remaining unvested awards would be forfeited.
• Schwartz said she would divest any UnitedHealth stock obtained through the exercise of vested stock options as soon as practicable, but no later than 90 days after confirmation, and recuse herself for two years from specific-party matters involving the company after the last cash payment.
• She also said she would resign from board positions at Butterfly Network and Aveanna Healthcare Holdings, divest stock in both within 90 days, and face additional recusal obligations tied to accelerated equity awards and compensation.
• Schwartz would resign from the Searching for Solutions Institute foundation and avoid acquiring direct financial interests in a wide range of industries affected by the Department of Health and Human Services, including pharmaceuticals, medical devices, healthcare, food, insurance, communications and software.
(Reporting by Puyaan Singh in Bengaluru, additional reporting by Jarrett Renshaw; Editing by Sahal Muhammed)
Comments